Consultile is a consulting and digital marketing firm that provides services to pharmaceutical companies. It aims to help clients make strategic decisions and adapt their strategies for business growth. Consultile offers management consulting, market research, marketing, and training services. Launching new drugs effectively is becoming more challenging due to factors such as fewer blockbuster drugs, more specialty launches, greater focus on value and outcomes, faster innovation cycles, and constrained resources. Consultile provides launch excellence services to help clients overcome challenges such as consistently applying a launch framework, ensuring launch teams focus on strategy, and maintaining real-time visibility of launch readiness.
As a Corporate Strategy Leader, you are under immense pressure to drive organizational success, align strategic initiatives, and ensure the effective allocation of resources to drive business outomes. OnePlan’s Strategic Portfolio Management Platform, powered by advanced AI, provides a comprehensive solution for managers looking to overcome these challenges with greater efficiency, insight, and impact. This webinar will explore how OnePlan’s SPM platform can transform strategic planning and execution within your organization. Learn How To:
Align Strategy and Execution: Discover how OnePlan ensures that every initiative aligns with your organization’s strategic objectives, optimizing outcomes and driving success.
Make Data-Driven Decisions: Learn how AI-powered analytics and predictive insights can empower managers to make informed decisions, anticipate future trends, and adapt strategies in real time.
Optimize Resources: Explore strategies for maximizing the use of available resources, reducing waste, and increasing ROI through intelligent planning and allocation features.
Collaborate with Transparency: Understand the importance of fostering a collaborative environment within the Corporate Strategy Office and across departments, facilitated by OnePlan’s centralized platform.
Manage Risk with Agility: See how OnePlan’s AI capabilities can help your team identify potential risks early, propose mitigation strategies, and maintain agility in the face of changing market conditions.
This webinar is designed for strategy executives, portfolio managers, and professionals involved in corporate planning and execution, who are looking to leverage advanced technologies to elevate their strategic processes and outcomes. Join us to uncover the transformative potential of OnePlan’s Strategic Portfolio Management Platform and AI for your Corporate Strategy Office.
As a Corporate Strategy Leader, you are under immense pressure to drive organizational success, align strategic initiatives, and ensure the effective allocation of resources to drive business outomes. OnePlan’s Strategic Portfolio Management Platform, powered by advanced AI, provides a comprehensive solution for managers looking to overcome these challenges with greater efficiency, insight, and impact. This webinar will explore how OnePlan’s SPM platform can transform strategic planning and execution within your organization. Learn How To:
Align Strategy and Execution: Discover how OnePlan ensures that every initiative aligns with your organization’s strategic objectives, optimizing outcomes and driving success.
Make Data-Driven Decisions: Learn how AI-powered analytics and predictive insights can empower managers to make informed decisions, anticipate future trends, and adapt strategies in real time.
Optimize Resources: Explore strategies for maximizing the use of available resources, reducing waste, and increasing ROI through intelligent planning and allocation features.
Collaborate with Transparency: Understand the importance of fostering a collaborative environment within the Corporate Strategy Office and across departments, facilitated by OnePlan’s centralized platform.
Manage Risk with Agility: See how OnePlan’s AI capabilities can help your team identify potential risks early, propose mitigation strategies, and maintain agility in the face of changing market conditions.
This webinar is designed for strategy executives, portfolio managers, and professionals involved in corporate planning and execution, who are looking to leverage advanced technologies to elevate their strategic processes and outcomes. Join us to uncover the transformative potential of OnePlan’s Strategic Portfolio Management Platform and AI for your Corporate Strategy Office.
May 2015 marked the final offering of Product Manager Imperatives at the University of Wisconsin-Madison’s Center for Professional and Executive Education. After 40 years of running these open enrollment corporate workshops on product management, UW-CPED has decided to focus exclusively on management and leadership training. This presentation is the condensed version of the final offering of Product Manager Imperatives. For a version of this presentation with links to videos, tutorials and other tidbits to demonstrate key points, look for this presentation at BrainSnacksCafe.
The presentation contains information about Strategic Planning, Levels of Strategy like Corporate Level Strategy, Business Level Strategy and Functional Level Strategy. The presentation also has many examples and a case study on diversification strategy.
Strong business processes are crucial for organizations to run their business effectively. Having good processes help organizations reduce their dependency on individuals. Good processes also help companies to scale up their operations and to be equipped to take on emerging market opportunities.
May 2015 marked the final offering of Product Manager Imperatives at the University of Wisconsin-Madison’s Center for Professional and Executive Education. After 40 years of running these open enrollment corporate workshops on product management, UW-CPED has decided to focus exclusively on management and leadership training. This presentation is the condensed version of the final offering of Product Manager Imperatives. For a version of this presentation with links to videos, tutorials and other tidbits to demonstrate key points, look for this presentation at BrainSnacksCafe.
The presentation contains information about Strategic Planning, Levels of Strategy like Corporate Level Strategy, Business Level Strategy and Functional Level Strategy. The presentation also has many examples and a case study on diversification strategy.
Strong business processes are crucial for organizations to run their business effectively. Having good processes help organizations reduce their dependency on individuals. Good processes also help companies to scale up their operations and to be equipped to take on emerging market opportunities.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
The Journey Toward Launch Excellence.pdf
1. Consultile| Uplifting Field Force Capabilities in Iraq | Proposal |
Acino | June 2021
The Journey Toward Launch Excellence
2. Consultile Middle East | Macro-economic outlook and
Pharmaceutical market overview in Egypt | March 2021
+ Consultile Capabilities
+ Launch Excellence
+ Five trends are changing the landscape of new drug launches
+ Providing a three-pillar framework for successful launch
planning
+ The Journey Toward Launch Excellence
+ Launch Process
+ The biggest challenges in launch planning for pharmaceuticals
+ Consultile Launch Excellence Services
Table of Contents
3. ABOUT US
Consultile is a consulting and Digital Marketing firm with experts
in healthcare and pharmaceutical industry.
We deliver solutions through leading-edge management
consulting along with technology. We work in a uniquely
collaborative model across the firm and throughout all levels of the
client organization, generating results that allow our clients to
thrive.
Consulting Services Technology Solutions
Our mission
is to partner with industry leaders to provide
innovative and integrated solutions to help
pharmaceutical companies take insightful strategic
decisions to grow and to adapt their strategies for
best business outcomes.
Company philosophy
Innovation and integrity are important values to our
business philosophy.
4. Consultile provides a broad range of assets and services to customers in
Life Sciences
Management Consulting
Department
Market Research Services Marketing Services Training Center
We deliver solutions through leading-edge management consulting along with technology. We work in a uniquely
collaborative model across the firm and throughout all levels of the client organization, generating results that allow our
clients to thrive.
5. Consultile Middle East | Macro-economic outlook and
Pharmaceutical market overview in Egypt | March 2021
+ Consultile Capabilities
+ Launch Excellence
+ Five trends are changing the landscape of new drug launches
+ Providing a three-pillar framework for successful launch
planning
+ The Journey Toward Launch Excellence
+ Launch Process
+ The biggest challenges in launch planning for pharmaceuticals
+ Consultile Launch Excellence Services
Table of Contents
6. Fewer
blockbusters
While companies used to launch a few large products each year,
they are now launching many small-to-mid size products instead,
with more intense competition. This growing emphasis on small-
to-medium-revenue products means that pharma companies are
developing wider and more fragmented product portfolios than
ever before. In turn, product launches increasingly need to be
tailored and customized to suit diverse product types. Additionally,
this means that there is stronger pressure for a quicker return on
investment (ROI).
7. Rise in
specialty
launches
The majority of new launches are increasingly targeted to smaller
patient populations, and around half of new drugs approved in the
US recently were specialty medicines. By their very nature, specialty
drugs require much more targeted launch efforts and a highly
customized approach, which means launch teams face a steep
learning curve. Biosimilars in particular present a new level of
complexity in the specialty market..
8. Focus on value
and outcomes
There has been a strong shift towards a greater focus on value
and outcomes, driven by the increasing importance of
functions such as Health Economics and Outcomes Research
(HEOR), managed care account management, and patient
advocacy services. Payers increasingly are putting pressure on
coverage and drug reimbursement, sometimes even
restricting access for patients.
9. As product technology development cycles have shortened over time,
companies need to continuously plan to think and stay ahead. This
dramatic acceleration of innovation means products typically have less
time on the market to recoup investment.
Acceleration of
innovation cycle
10. s3
With continuous pressures on bottom-lines, there is an
overwhelming need to ‘do more with less’. Diminishing
firm-wide launch capabilities mean launch resourcing is
often sub-optimal. Balancing speed-to-market with
proper launch preparation is putting more pressure on
resources than ever before. In such an environment,
adaptability is often the key to success.
Doing more
with less
11. A three-pillar framework for successful launch planning
A foundation of strong capabilities in each of these areas is critical to the success of the launch.
Market
A foundation of strong capabilities
Targeted market shaping activities to drive
access, uptake, adherence, and advocacy.
Leveraging insights and positioning
to optimize value to the patient
Coordinated and adequate resourcing, training,
and mobilization across functions
12. Define & Build
Process Training & Roll Out
Transform & Perform
Sustain & Improve
• In the first stage, companies need to define global, regional and country launch excellence for their organizations. Existing
materials can be leveraged to build the launch excellence framework and tools.
• Next, define a plan for launch excellence implementation and change management/communication.
• This is the most important step in building a robust foundation for launch excellence within the organization. This stage takes
time as it touches on sensitive topics and requires changes in how the organization operates in a launch mode.
• In stage two, launch excellence can be piloted with launch teams to test the process and ensure it
works. The process built in stage one may need to be refined based on the pilot studies.
• The launch excellence resources, such as framework, tools and templates, can then be rolled out
with training materials to ensure quality execution is continuously being developed.
• In stage three of the journey, ongoing launch excellence support should be provided to the
launch teams. Leaders must drive sustained launch excellence utilization, measure impact and
maintain and refine processes.
• Successes and best practices should consistently be captured and shared across the
organization
• Stage four involves managing launch excellence processes, collecting and incorporating feedback and adapting to
business-driven changes.
• Successes and best practices should continue to be shared while developing launch excellence experts to build
sustainability
The Journey Toward Launch Excellence
13. LAUNCH PROCESSES
Achieving launch excellence is a journey with multiple stages requiring constant engagement and refinement
01
Market Research
02
Planning
03
Execution
04
Launch Readiness
07
Insight
Generation
06
Launch
Tracking
08
MANAGE-
MENT
05
Excellence
Tracking
Market Research
Do you know your market?
The market research process is a
systematic method for business
decisions based on market data
analysis and results.
Planning
How to launch as planned?
The 'Planning' process handles the
activity. project and budget planning
for each product launch.
Execution
Are you progressing as planned?
Identify potential issues and ensure
that resources and funds are
prioritized efficiently.
Launch Readiness
Are you ready to launch ?
Each launch has its own
checklist and activity assessment to
measure the quality of the launch
activities.
Excellence Tracking
Are the processes being followed?
Excellence tracking is about applying
a governance on processes themselves
and define criteria for ideal usage of tools
and modules.
Launch Tracking
How is your product performing?
This is a data driven process. which should
provide answers on product uptake and
forecasting.
Insight Generation
How improve launch activities?
Insights are generated by
systematically investigation of
various data sources.
14.
15. Challenge #1
Embedding a launch framework consistently across the company
The launch framework must be understood, accepted and applied
systematically throughout the organization, and across brands, therapy
areas, local affiliates and functional silos.
That way, companies can avoid continuously re-inventing the wheel and
diluting best practices.
A common framework will guard against difficulties such as:
▪ Information lags in launch tracking.
▪ lack of clarity over timelines, budgets or key performance indicators.
▪ Fragmentation of resources (human or otherwise).
▪ Poor co-ordination and local discrepancies.
▪ Strategic misalignment.
▪ Last-minute reversals to the pharma launch plan.
16. Challenge #2
Ensuring that key personnel are focused on strategic priorities, rather
than on time-consuming administrative distractions.
Key members of the launch team often get embroiled in
time-consuming administrative distractions, such as
chasing teams for timelines and activity status, collecting,
processing, and consolidating data, or manually preparing
reports and presentations.
A collaborative launch management platform, should
streamline and automate these tasks. In doing so, it will
save your team members time, so that they can focus on
strategy and executing with excellence
COMMUNICATION
TIME MANAGEMENT
SCHEDULING
BUDGETING
1
2
3
4
5
EXECUTE
SUPPORT
IMPLEMENT
STRATEGIZE PLAN
17. Challenge #3
Making sure you have real-time visibility of
launch readiness across the organization,
both at global and local level.
Real-time visibility of launch readiness, timelines and
status can keep these imperatives front of mind.
Chasing markets for updates, or collecting and
consolidating data from poorly aligned launch readiness
tools, may leave key personnel struggling to claw back
vital time for launch strategy and implementation.
All internal stakeholders need to be on the same page
about launch progress from market to market, regardless
of national boundaries, functional silos or position within
the organization.
Any number of local issues can bring about changes in
status and timelines that undermine careful launch
scheduling.
18. Consultile Middle East | Macro-economic outlook and
Pharmaceutical market overview in Egypt | March 2021
+ Consultile Capabilities
+ Launch Excellence
+ Five trends are changing the landscape of new drug launches
+ Providing a three-pillar framework for successful launch
planning
+ The Journey Toward Launch Excellence
+ Launch Process
+ The biggest challenges in launch planning for pharmaceuticals
+ Consultile Launch Excellence Services
Table of Contents
19. Consultile Launch Excellence S e r v i c e s
• Acceptance of KOLs for your new
products
• Acceptable price range
• Estimated Rx. share
• Performance diagnostic
• Brand excellence framework
• Super KPIs framework
• Where do your target patient diagnosed
and at which stage?
• Which specialty treat them and when do
they refer them to other specialties and
when?
• Which guidelines do physician follow
and why?
Market
understanding and
forecasting
• Develop market understanding for your
product and key competitors
• Market forecasting for next 5 years and
opportunity evaluation
• Patient epidemiology forecast including
number or patients, % of diagnosed patients
and treated patients.
Patient Journey
and Referral
Pathway
Performance
measurements
Test Value
Preposition
I II
III IV
20. Please Contact Us for More Information
Mohamed Salem
Principle Management Consulting; Middle
East
Mohamed.salem@consultile.com
+2 010 269 12348
Afnan Sabry
Business Development Manager
Afnan.sabry@consultile.com
+2 011 431 5328
Mohamed Ahmed
Principle Marketing Services; Middle East
Mohamed.ahmed@consultile.com
+2 012 739 06129